Company page

Ipsen Sa

Ipsen Sa is a public company listed on the French market under the ticker IPN, with a market capitalization of approximately €15.34 billion. The company is involved in the biopharmaceutical sector, focusing on innovative medicines for various therapeutic areas. Ipsen is committed to improving patient outcomes through its research and development efforts.

IPN:EURONEXTUpdated July 24, 2026
Ipsen Sa logo
Ticker
IPN:EURONEXT
Asset type
Stock
Market cap
$15.34B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
EURONEXT
Currency
EUR